Valuation: MedCap AB

Market Cap 8.03B 810M 722M 668M 608M 1.14B 76.88B 1.16B 3.15B 40.12B 3.04B 2.97B 129B P/E 2026 *
32.4x
P/E 2027 * 27.2x
Enterprise Value 8.12B 818M 730M 675M 614M 1.16B 77.7B 1.18B 3.19B 40.55B 3.07B 3.01B 130B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 2.93x
Free-Float
88.3%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week+4.17%
Current month+2.39%
1 month+1.23%
3 months+4.38%
6 months+3.97%
Current year-2.28%
1 week 516.5
Extreme 516.5
543.5
1 month 499.2
Extreme 499.2
544.5
Current year 440
Extreme 440
582
1 year 440
Extreme 440
636
3 years 247
Extreme 247
677
5 years 135
Extreme 135
677
10 years 27
Extreme 27
677
Manager TitleAgeSince
Chief Executive Officer 50 31/10/2020
Director of Finance/CFO 52 29/04/2020
Corporate Officer/Principal 54 31/12/2019
Director TitleAgeSince
Chairman 52 31/12/2007
Director/Board Member 63 30/04/2022
Director/Board Member 66 30/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
09/02/26 Buy 1,500 0.0099%
09/02/26
Anders Larnholt Forvaltning AB
SellCompany 1,500 0.0099%
06/02/26 Sell 500 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+4.17%-3.33%+102.84% 811M
+1.21%+4.80%-2.31%+83.95% 175B
+0.53%-0.68%+30.88%+79.97% 147B
+0.85%+0.41%+35.21%+232.10% 96.43B
-2.37%-6.72%-31.80%+4.21% 85.28B
-0.96%-2.23%-16.84%+72.18% 81.7B
-1.62%-5.21%-26.69%+48.77% 77.39B
-1.84%-2.26%-15.65%+43.49% 72.31B
-1.12%-5.28%+48.80%+141.47% 45.21B
-0.35%+0.06%+6.50%+54.78% 44.24B
Average -0.44%-1.05%+2.48%+86.38% 82.6B
Weighted average by Cap. -0.28%-0.80%+3.32%+85.90%

Financials

2026 *2027 *
Net sales 2.4B 242M 216M 199M 181M 342M 22.95B 347M 942M 11.98B 907M 888M 38.46B 2.69B 271M 241M 223M 203M 383M 25.71B 389M 1.05B 13.42B 1.02B 995M 43.09B
Net income 256M 25.75M 22.96M 21.23M 19.33M 36.39M 2.44B 36.99M 100M 1.28B 96.62M 94.57M 4.1B 317M 31.94M 28.49M 26.34M 23.98M 45.15M 3.03B 45.9M 124M 1.58B 120M 117M 5.08B
Net Debt 85M 8.56M 7.64M 7.06M 6.43M 12.11M 813M 12.31M 33.37M 424M 32.14M 31.46M 1.36B -148M -14.96M -13.35M -12.34M -11.24M -21.15M -1.42B -21.5M -58.3M -742M -56.16M -54.96M -2.38B
Projected Income Statement - Annual - MedCap AB
Logo MedCap AB
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Employees
647
Date Price Change Volume
16/10/26 SEK 536.50 +1.23% 11,986
15/10/26 SEK 530.00 -1.30% 14,355
14/10/26 SEK 537.00 +1.80% 12,932
13/10/26 SEK 527.50 0.00% 10,251
12/10/26 SEK 527.50 +2.43% 20,275
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
MarketScreener Ratings - MedCap AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
536.50SEK
Average target price
640.00SEK
Spread / Average Target
+19.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MedCap AB
  1. Stock Market
  2. Stocks
  3. MCAP Stock